4 reports

The drug candidate acts by blocking the histamine receptors and prevents the excess mucus production associated with ocular allergy.

  • Antifungal
  • Diagnostics
  • Ear Disease
  • Pharmaceutical
  • Sensorion S.A.

Efficacy was evaluated at Night ## (first drug administration) and after ## weeks of drug administration (Night ##).

  • Diagnostics
  • Sleep Aid
  • United States
  • Product Initiative
  • Eisai Co., Ltd.

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Diagnostics
  • Monoclonal Antibody
  • United States
  • SCYNEXIS, Inc.

CY-## - DRUG PROFILE DORA-## - DRUG PROFILE DRGT-## - DRUG PROFILE DRUG FOR INSOMNIA - DRUG PROFILE DRUGS TO INHIBIT ANGIOTENSIN II RECEPTOR TYPE ## FOR INSOMNIA - DRUG PROFILE EVT-## - DRUG PROFILE Drug Name C

  • Diagnostics
  • Psychotic Disorder
  • Sleep Aid
  • United States
  • Product Initiative